Log In
BCIQ
Print this Print this
 

PK Levo

  Manage Alerts
Collapse Summary General Information
Company Merz GmbH & Co. KGaA
DescriptionCombination of levodopa and benserazid
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today